The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparative effectiveness and safety of the implementation of universal public funding of FOLFIRINOX (FFX) and gemcitabine (G) + nab-paclitaxel (GnP) in advanced pancreatic cancer (APC): A population-based study.
 
Helen Guo
No Relationships to Disclose
 
Jaclyn Marie Beca
No Relationships to Disclose
 
Ruby Redmond-Misner
No Relationships to Disclose
 
Wanrudee Isaranuwatchai
No Relationships to Disclose
 
Lucy Qiao
No Relationships to Disclose
 
Craig Earle
Patents, Royalties, Other Intellectual Property - UpToDate
 
Scott R. Berry
No Relationships to Disclose
 
James Joseph Biagi
No Relationships to Disclose
 
Stephen Welch
Honoraria - Amgen; AstraZeneca; Celgene
Consulting or Advisory Role - Amgen
 
Brandon Matthew Meyers
Stock and Other Ownership Interests - Bitanka
Honoraria - Amgen; Sanofi
Consulting or Advisory Role - Celgene; Ipsen
 
Nicole Mittmann
No Relationships to Disclose
 
Natalie G. Coburn
No Relationships to Disclose
 
Aliya Pardhan
No Relationships to Disclose
 
Jessica Arias
No Relationships to Disclose
 
Deborah Schwartz
No Relationships to Disclose
 
Scott Gavura
No Relationships to Disclose
 
Leta Marie Forbes
No Relationships to Disclose
 
Robin McLeod
No Relationships to Disclose
 
Erin Diane Kennedy
No Relationships to Disclose
 
Kelvin K. Chan
No Relationships to Disclose